Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,807 | 24,212 | 4,565 | 2,957 | 1,886 |
| TOTAL | $75,996 | $24,618 | $4,664 | $3,285 | $2,063 |
| Non-Current Assets | |||||
| PPE Net | 75 | 53 | 15 | 7 | 12 |
| Other Non-Current Assets | 0 | 2,161 | 1,385 | 1,173 | 885 |
| TOTAL | $75 | $2,214 | $1,400 | $1,180 | $897 |
| Total Assets | $76,071 | $26,832 | $6,064 | $4,465 | $2,960 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,966 | 3,240 | 1,145 | 1,151 | 2,043 |
| Accrued Expenses | 586 | 558 | 253 | 147 | 355 |
| TOTAL | $3,552 | $3,798 | $1,398 | $1,298 | $2,398 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,552 | $3,798 | $1,398 | $1,298 | $2,398 |
| Shareholders' Equity | |||||
| Common Shares | 23 | 17 | 12 | 9 | 6 |
| Retained earnings | -240,529 | -209,902 | -191,735 | -179,244 | -174,476 |
| Other shareholders' equity | -380 | -380 | -380 | -380 | -380 |
| TOTAL | $72,519 | $23,034 | $4,666 | $3,167 | $562 |
| Total Liabilities And Equity | $76,071 | $26,832 | $6,064 | $4,465 | $2,960 |